Skip to content

Betamethasone

  • Prescription medicine
  • Prescription only
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Betamethasone does in the body

Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).

From the FDA-approved label: Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action of SERNIVO Spray in psoriasis is unknown. 1 How Supplied/Storage SERNIVO Spray is a slightly thickened, white to off-white, non-sterile emulsion supplied in high density polyethylene bottles with a heat induction seal lined polypropylene cap.

Why people take it. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
RNAWiki has not recorded a supervision or regulatory status for this substance.
Where each sentence above came from

The use the label states, quoted from it. No plain-language version of this sentence has been written.

The use the label states, quoted from it. It is written for a clinician, not for a reader without medical training.

No statement of the main limit is recorded.

The four opening statements run to 100 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Formulation

A formulation is the exact made-up form a substance comes in.

A picture of it, and where the picture fails

It is like the difference between a whole bean and instant coffee.

Where that stops being true. Coffee tastes different. A formulation can change how much reaches the blood.

What people get wrong. Two products with the same name are assumed to behave the same. They often do not.

The specific composition and physical form of a product, including salt, excipients and release profile.

Enzyme

An enzyme is a protein that speeds up one chemical change.

A picture of it, and where the picture fails

An enzyme is like a machine on a production line doing one cut.

Where that stops being true. A machine is switched on and off by a person. Enzymes are controlled by the cell.

What people get wrong. Enzymes are thought to be used up. They are not; they work again and again.

A catalytic protein that lowers the activation energy of a specific reaction.

Receptor

A receptor is a part of a cell that a signal fits into.

A picture of it, and where the picture fails

A receptor is like a lock waiting for one key.

Where that stops being true. A lock either opens or does not. A receptor can be half-triggered, or worn out.

What people get wrong. Fitting a receptor is read as causing a benefit. It causes a step, and nothing more.

A protein that binds a specific ligand and converts that binding into a cellular response.

Pathway

A pathway is a chain of steps inside a cell, each one setting off the next.

A picture of it, and where the picture fails

A pathway is like a row of dominoes.

Where that stops being true. Dominoes fall one way. Pathways loop back and can switch themselves off.

What people get wrong. Changing one step is read as changing the outcome. Other steps often absorb it.

An ordered series of molecular interactions producing a defined cellular change.

What happened in peopleRead from sources, not yet reviewed

What was measured, goal by goal

One row for each goal a registered study measured something for. One column for each kind of thing that could be measured.

Registered studies list 40 outcome measures that RNAWiki could read. A registered study says what someone planned to measure. It does not say what they found. 0 of the matched studies tested this substance, and 0 posted a result.

There is no single score. A strong test result and a weak life result are different facts.

Goals down the side, kinds of measurement across the top. Each cell says what kind of thing was registered, not what was found.
GoalLife outcomeWhat a body can doHow a person feelsA test resultA step in the bodyHarmsHow longWho was studied
PainNothing in the sources checkedNo registered study lists a life outcome for this goal.Waiting for a reviewer1 registered performance measure of this kind.Waiting for a reviewer11 registered symptom measure.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Healthy ageingWaiting for a reviewer1 registered study measure of this kind. No reviewed result yet.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
StrengthNothing in the sources checkedNo registered study lists a life outcome for this goal.Waiting for a reviewer1 registered performance measure of this kind.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Which registered measures put each goal on this table
Pain
visual analogue pain; pain improvement; injection pain as measured by vas for both treatment groups; visual analog scale of pain finklestein test; pain; pain scores; pain vas; pain severity
Healthy ageing
all cause mortality
Strength
strength

Sorted by fixed word lists, version v1. A name the rules do not recognise stays unsorted rather than moving to the nearest column.

What each mark on this table means
Nothing in the sources checked
No registered study lists a life outcome for this goal.
Waiting for a reviewer
1 registered performance measure of this kind.
Not recorded
Harms were not a registered measure for this goal.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Perinatal Mortality or Substantial Neonatal Morbidity

The study did not show it

Who was studied
NCT05114096
How many people
3254
Study design
Phase 4
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Topical

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

severe RDS defined as need for exogenous intra-tracheal surfactant in the first 48 hours of life

The study did not show it

Who was studied
NCT02897076
How many people
3250
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Topical

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Neonatal Composite Outcome

The study did not show it

Who was studied
NCT01222247
How many people
2831
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Topical

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Respiratory morbidity

The study did not show it

Who was studied
NCT05698966
How many people
1510
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Topical

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Overall disease severity according to investigator's assessment at week 8

The study did not show it

Who was studied
NCT00216827
How many people
1485
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Topical

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

- Patients with "Controlled disease" ("Absence of disease" or "Very mild disease") according to investigator's global assessment of disease severity at week 8.

The study did not show it

Who was studied
NCT00216840
How many people
1350
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Topical

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What happened in peopleRead from sources, not yet reviewed

How close this is to real life

The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.

  1. Living longer, or avoiding a major event Evidence recorded. Death, a heart attack, a stroke, a hospital stay.1 registered measure of this kind. No reviewed result.
  2. What a body can do day to day Evidence recorded. Walking, dressing, breathing, recovering.2 registered measures of this kind.
  3. Measured performance Evidence recorded. How much was lifted, how far was run, how fast.2 registered measures of this kind.
  4. Symptoms and quality of life Evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.12 registered measures of this kind.
  5. A number that stands in for health No evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.No registered study measures this.
  6. A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.A human record sits on the stored organism ladder.
  7. Animals Evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.Stored records in Rat. A result in animals says what to test next. It does not say what happens in people.
  8. Cells in a dish No evidence recorded. Cells or chemistry on a bench, far from a whole body.No cell or bench record is stored.
  9. A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.

Higher on these steps means closer to something a person would feel. It does not mean better done.

What it would be like to takeRead from sources, not yet reviewed

Felt, measured, or meaningful

Three different things that get called the same word. Registered studies measured all three, and mixing them is how a blood test becomes a health claim.

Felt

Things a person could notice without a test.

  • visual analogue pain
  • global impression of change
  • pain improvement
  • injection pain as measured by vas for both treatment groups
  • visual analog scale of pain finklestein test
  • pain
  • pain scores
  • pain vas
  • pain severity
  • incidence of pain

and 2 more.

Measured

Things only a test, a scale or a device shows.

  • strength

Meaningful

Things that change how a life goes, not only a number.

  • all cause mortality
  • shoulder pain and disability index

A registered study says what someone planned to measure. It does not say what they found. A number moving is not the same as a life going better. The two are shown apart here.

Felt, but not shown to help. A person notices a change. No study showed it leads anywhere good.

Measured, but not felt. A number moves. The person notices nothing. Both can be true.

Measured, but not shown to matter. A number moves in the good direction. Nobody showed that lives went better.

Matters, but takes years. The result that counts may take longer than anyone would keep watching.

Names that fit none of the three (25)
  • neonatal respiratory distress
  • constant
  • neonatal composite outcome
  • sore throat
  • cough
  • intraocular pressure
  • total sign change
  • postoperative nausea and vomiting
  • caloric function
  • based on visual analog scale and size of the lesion
  • opiate consumption
  • resolution of symptoms
  • treatment emergent adverse events
  • laboratory test abnormalities
  • clinical response rate
  • range of motion
  • acute radiation dermatitis grading
  • time to first new flare
  • numeric rating scale
  • treatment related adverse events assessed by nci ctcae

These are harms, study-process measures, or names the rules did not recognise. They are shown rather than dropped.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

People similar to this profile were included.

  • When oral therapy is not feasible, the intramuscular use of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated as follows: Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis,…

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What the label states about particular groups

  • On pediatric, the label states: “The efficacy and safety of corticosteroids in the pediatric population are based on the well-established course of effect of corticosteroids, which is similar in pediatric and adult populations.”

    US prescribing information · a363b861-4873-465e-8009-0e9690666224 · read 2026-08-30

  • On older people, the label states: “No overall differences in safety or effectiveness were observed between elderly subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and young patients, but greater sensitivity of some older individuals cannot be ruled out.”

    US prescribing information · a363b861-4873-465e-8009-0e9690666224 · read 2026-08-30

  • On people who are pregnant, the label states: “Teratogenic Effects Corticosteroids have been shown to be teratogenic in many species when given in doses equivalent to the human dose.”

    US prescribing information · a363b861-4873-465e-8009-0e9690666224 · read 2026-08-30

  • On people who are breastfeeding, the label states: “Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects.”

    US prescribing information · a363b861-4873-465e-8009-0e9690666224 · read 2026-08-30

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied for a different goal

The studies measured something else entirely.

On this record: Some registered studies measured things that match no goal on this page.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

A different form was studied

The studied form is not the form on the shelf.

On this record: This record is linked to 1 related forms. Evidence does not carry across all of them.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (9)
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Prescription only

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Topical

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form and route recorded on this substance.

No source is stored against this line.

Who oversees it

RNAWiki has not recorded a supervision or regulatory status for this substance.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

No register row and no identity class settled the question.

No source is stored against this line.

What is in the pack

Sold as gel, augmented, lotion, augmented, cream, ointment, given by the topical, oral, injection route.

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

Recorded notes on how this is sold and what that means for what is in the pack.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Reports sent to a regulator

  • These are reports people sent to a regulator. They do not show the medicine caused the reaction.
  • Nobody counted how many people took the medicine and reported nothing.
  • The same event can be reported more than once, and many reports are incomplete.
  • News coverage, lawsuits and new warnings change how often people report.
  • A count is not a rate and not a risk.

Betamethasone appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 1262 reaction mentions were counted. One report can name several reactions.

The recorded terms (10)
  • premature baby — 161 reaction mentions
  • pain in extremity — 149 reaction mentions
  • hypersensitivity — 139 reaction mentions
  • urticaria — 138 reaction mentions
  • pneumonia — 134 reaction mentions
  • hepatic function abnormal — 120 reaction mentions
  • muscle spasms — 120 reaction mentions
  • stomatitis — 113 reaction mentions
  • epistaxis — 110 reaction mentions
  • erythema — 78 reaction mentions
  • open-targets-adr · recorded 2026-06-24 · a recorded source, not a stored snapshot

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Topical

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form used in the studies cited on this page.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 31 products list this as an active ingredient in the United States drug directory. 31 of them contain it and nothing else.

    FDA National Drug Code directory · 0517-0720 · read 2026-08-29

  • They are sold as injection, suspension and powder, taken intra-articular, intralesional, intramuscular and soft tissue.

    FDA National Drug Code directory · 0517-0720 · read 2026-08-29

  • The regulator's established pharmacologic class for it is corticosteroid hormone receptor agonists [moa] and corticosteroid [epc].

    FDA National Drug Code directory · 0517-0720 · read 2026-08-29

  • 8 published labels name it as an active ingredient. 8 of them describe this substance alone, which is where its own label text on this page comes from.

    US prescribing information · a363b861-4873-465e-8009-0e9690666224 · read 2026-08-29

  • Those labels are classed as human prescription drug.

    US prescribing information · a363b861-4873-465e-8009-0e9690666224 · read 2026-08-29

  • Betamethasone Sodium Phosphate and Betamethasone Acetate is intra-articular at HOW SUPPLIED NDC 0517-0720-01: Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, 5 mL multiple-dose vial; box of one., recorded as fda label in effect 2024-09-05 in the United States.

    US prescribing information · a363b861-4873-465e-8009-0e9690666224 · read 2026-08-30

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

Names and forms linked to this record

  • Stereoisomer of

    Dexamethasone

    Evidence on this page does not automatically apply to this one.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

RNAWiki could not confidently classify this substance, so no self-experiment plan is offered.

Questions worth asking

  • Which of the trials of Betamethasone studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

How fast does the body clear it?

The sources RNAWiki checked hold nothing for this field.

Why it matters. Without this, nothing on this page can say how long anything lasts.

What would answer it

A stored source that records it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Betamethasone are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleNothing found in the sources checked

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Nothing found in the sources checked

No traced study record is stored for this substance.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Passed

    Every public sentence names a source

    The opening statement carries the origin: Quoted from a stored source.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Not passed

    Safety mode resolved

    No register row and no identity class settled the question.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

How this medicine reached us

Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.

What the approval register records

  • 8 approved applications cover products containing this substance. The earliest was NDA012657, approved 19610417 to SCHERING.

    Drugs@FDA application register · NDA012657 · read 2026-08-29

  • Marketing status on the register: discontinued and prescription.

    Drugs@FDA application register · NDA012657 · read 2026-08-29

  • The earliest marketing start date recorded for a listed product is 19650303.

    FDA National Drug Code directory · 0517-0720 · read 2026-08-29

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

6 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • The path through the body — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (12)

What did Betamethasone's largest trial (3250 people) and its longest (12 years) measure?


3250 people in Betamethasone's largest registered study, 12 years in its longest registered window, measuring Composite outcome: including neonatal mortality/stillbirth, severe RDS, chronic lung disease, grade III/IV IVH, PVL. ClinicalTrials.gov · 2026-09-01

28 phase4, 27 phase2, 23 phase3, 20 na, 15 phase1, 7 na or unstated, 1 early phase1; NCT01222247; 2022-08-31; no ageing endpoint recorded. Last human test completed 2025, NCT06626568.

Interpretation These counts include studies where Betamethasone was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.

Show the evidence
  • phase4
    28
  • phase2
    27
  • phase3
    23
  • na
    20
  • phase1
    15
  • na or unstated
    7
2 more recorded rows
  • early phase1
    1
  • Last recorded human test NCT06626568
    2025-09-02

recorded 2026-09-01 · last checked 2026-09-04

From rat to human: where has Betamethasone shown lifespan?


rat: lifespan and human: lifespan (111): the rungs where Betamethasone has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01

Interpretation Composite outcome: including neonatal mortality/stillbirth, severe RDS, chronic lung disease, grade III/IV IVH, PVL — the recorded outcome words.

Yeast C. elegans Drosophila Mouse Rat lifespanDog Non-human primate Human lifespan
Show the evidence
  • rat
    lifespan
  • human NCT00015002
    lifespan; Composite outcome: including neonatal mortality/stillbirth, severe RDS, chronic lung disease, grade III/IV IVH, PVL; 111

recorded 2026-09-01 · last checked 2026-09-04

16 of Betamethasone's trials stopped: safety, accrual/recruitment, funding/business, other?


safety (1), accrual/recruitment (5), funding/business (2) and other (8): Betamethasone's stop wording, clustered. ClinicalTrials.gov · 2026-09-01

"Concerns regarding neonatal data"; 16 of 111 registered studies

Show the evidence

Trial

  • NCT00015002
    terminated; "Concerns regarding neonatal data"
  • NCT00139256
    terminated; "Slow enrollment and lack of funds."
  • NCT00670956
    terminated; "Recruitment has been poor. Study drug is being offered as part of standard care of women carrying a pregnancy diagnosed with CCAM"
  • NCT00685880
    terminated; "Unable to recruit adequate numbers of patients"
  • NCT00914836
    withdrawn; "difficulties in the department"
  • NCT00933023
    withdrawn; "Patient numbers estimated to be too low to complete the trial in less than 10 years"
10 further recorded trials
  • NCT02038634
    terminated; "not enough patient data"
  • NCT02351310
    withdrawn; "Company decided not to pursue this study."
  • NCT02527421
    terminated; "Not able to recruit patients with the current enrollment criteria."
  • NCT02586961
    terminated; "Removal of Adrénaline lots for safety reasons."
  • NCT02912182
    terminated; "Placebo medication expired"
  • NCT02939742
    terminated; "Low study recruitment"
  • NCT03395132
    terminated; "Due to business strategic reasons, LEO Pharma has decided to close down the FCF-38 trial."
  • NCT03770546
    withdrawn; "Failure of institution to reach agreement with company supplying injections"
  • NCT04931511
    terminated; "Since the COVID-19 pendemic, the regular follow-up of participant became very hard. The participant were not willing to go back to the hospital for repeat measurement. So we stop the study and plan to redesign the protocol."
  • NCT07297264
    terminated; "There was a change in the protocol of the study"

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Betamethasone used Betamethasone 4 mg — over how long?


Human studies of Betamethasone used "Betamethasone 4 mg". ClinicalTrials.gov · 2026-09-01

11 recorded entries; human; also "calcipotriol 50 mcg/g and betamethasone 0.5 mg/g (as dipropionate)", "betamethasone 24 mg", "12mg betamethasone +placebo"

Show the evidence

human

  • NCT01033097
    Betamethasone 4 mg
  • NCT01536938
    calcipotriol 50 mcg/g and betamethasone 0.5 mg/g (as dipropionate)
  • NCT02897076
    betamethasone 24 mg
  • NCT02897076
    12mg betamethasone +placebo
  • NCT03026478
    Betamethasone Dipropionate 0.05% gel
  • NCT03117894
    Betamethason 4 mg
5 more recorded rows
  • human NCT03668860
    Betamethasone 4 mg/ml
  • human NCT03668860
    Celestone Soluspan 6Mg/Ml Suspension for Injection
  • human NCT03758365
    Betamethasone Dipropionate 0.05% Cream
  • human NCT04494529
    12 mg betamethasone + placebo
  • human NCT04494529
    24 mg betamethasone

recorded 2026-09-01 · last checked 2026-09-04

Could one person measure Betamethasone's effect on neonatal respiratory distress?


Neonatal respiratory distress: measured in Betamethasone's trials.

Interpretation neonatal respiratory distress is the recorded endpoint.

Show the evidence

biomarkers

  • neonatal respiratory distress; 2026-09-01
  • visual analogue pain; 2026-09-01
  • constant; 2026-09-01
  • neonatal composite outcome; 2026-09-01
  • global impression of change; 2026-09-01
  • pain improvement; 2026-09-01
14 more recorded rows
  • biomarkers
    injection pain as measured by vas for both treatment groups; 2026-09-01
  • biomarkers
    sore throat; 2026-09-01
  • biomarkers
    cough; 2026-09-01
  • biomarkers
    intraocular pressure; 2026-09-01
  • biomarkers
    total sign change; 2026-09-01
  • biomarkers
    visual analog scale of pain finklestein test; 2026-09-01
  • biomarkers
    postoperative nausea and vomiting; 2026-09-01
  • biomarkers
    pain; 2026-09-01
  • biomarkers
    caloric function; 2026-09-01
  • biomarkers
    pain scores; 2026-09-01
  • biomarkers
    based on visual analog scale and size of the lesion; 2026-09-01
  • biomarkers
    opiate consumption; 2026-09-01
  • biomarkers
    all cause mortality; 2026-09-01
  • biomarkers
    resolution of symptoms; 2026-09-01
  • human trials at or under30
    31
  • Not recorded for this substance
    a recorded half-life
  • smallest human trial
    0; NCT00914836; NA; the smallest recorded human enrolment at or below 30; the registry states no direction of its result; WITHDRAWN

Which of acute and chronic postoperative pain, acute radiation dermatitis grading and all cause mortality did Betamethasone's trials measure?


acute and chronic postoperative pain, acute radiation dermatitis grading and all cause mortality lead 40 outcome terms across Betamethasone's trials. ClinicalTrials.gov · 2026-09-01

Interpretation neonatal composite outcome, global impression of change, pain improvement, injection pain as measured by vas for both treatment groups, sore throat and cough follow.

Show the evidence
  • neonatal respiratory distress
    1
  • visual analogue pain
    1
  • constant
    1
  • neonatal composite outcome
    1
  • global impression of change
    1
  • pain improvement
    1
14 more recorded rows
  • injection pain as measured by vas for both treatment groups
    1
  • sore throat
    1
  • cough
    1
  • intraocular pressure
    1
  • total sign change
    1
  • visual analog scale of pain finklestein test
    1
  • postoperative nausea and vomiting
    1
  • pain
    1
  • caloric function
    1
  • pain scores
    1
  • based on visual analog scale and size of the lesion
    1
  • opiate consumption
    1
  • all cause mortality
    1
  • resolution of symptoms
    1

recorded 2026-09-01 · last checked 2026-09-04

Which of Betamethasone's 11 ongoing trials reports first?


11 registered trials of Betamethasone are open; earliest completion 2025-10-15. ClinicalTrials.gov · 2026-09-01

To collect and evaluate single-cell multiomics data (RNAseq, CITEseq, TCRseq); Mean number of accelerations on fetal cardiotocography; latest 2031-01

Show the evidence

Trial

  • NCT05535738
    "Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation"; n 45; "To collect and evaluate single-cell multiomics data (RNAseq, CITEseq, TCRseq)"; 2027-12-31
  • NCT07078786
    "Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace"; n 110; "Mean number of accelerations on fetal cardiotocography"; 2025-10-15
  • NCT07341776
    "Steroid Use in Treatment of Allergic Reactions to Food"; n 160; "Time to complete resolution of allergic symptoms"; 2026-12
  • NCT07348016
    "Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial"; n 70; "Change in Constant-Murley Shoulder Score"; 2028-12-01
  • NCT07409779
    "Capsular Distension Versus Corticosteroid Injection in Adhesive Capsulitis"; n 50; "Shoulder Pain Intensity (Visual Analog Scale)"; 2026-12
  • NCT07416916
    "Ultrasound-Guided Intra-Articular vs Gluteal Intramuscular Corticosteroid Injection for Frozen Shoulder"; n 528; "Change in Shoulder Pain and Disability Index (SPADI) Total Score from Baseline to Week 8"; 2031-01
5 further recorded trials
  • NCT07447739
    "Can Betamethasone Given After Birth Help Extremely Premature Babies Come Off Breathing Support Safely and Effectively?"; n 100; "The rate of successful respiratory weaning"; 2029-03
  • NCT07453004
    "A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis"; n 170; "Visual Analogue Scale(VAS) score"; 2027-12-31
  • NCT07547605
    "PRP vs PRP+Betamethasone vs Betamethasone Injection for Upper Trapezius Myofascial Pain"; n 150; "Change in Visual Analog Scale (VAS) Pain Score"; 2027-01
  • NCT07668895
    "Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis"; n 126; "Change from baseline in percent predicted FVC after 24 weeks of treatment (%)"; 2028-07
  • NCT07681804
    "Betamethasone vs Dextrose Injections in Trigger Finger"; n 42; "Change in pain intensity assessed by Numeric Rating Scale (NRS)"; 2027-05

recorded 2026-09-01 · last checked 2026-09-04

Which 40 trials of Betamethasone posted no result?


Posted no result
40 of 40 completed trials
Registrations
NCT00358384, NCT00963573, NCT00576238, NCT00576550, NCT00542139 and NCT00910676, and 34 more
Completion dates
oldest 2006-02-24; newest 2024-07-26
Show the evidence

Trial

  • NCT00358384
    2006-02-24
  • NCT00963573
    2006-11
  • NCT00576238
    2008-02
  • NCT00576550
    2008-05
  • NCT00542139
    2008-11
  • NCT00910676
    2009-03
14 further recorded trials
  • NCT00675246
    2010-05
  • NCT01033097
    2011-07
  • NCT01466478
    2011-12
  • NCT01071369
    2012-06
  • NCT01646567
    2012-11
  • NCT02114021
    2013-03
  • NCT00446953
    2013-11
  • NCT02575729
    2014-07
  • NCT02066844
    2014-08
  • NCT02114073
    2015-02
  • NCT01885481
    2015-04
  • NCT02376049
    2015-07
  • NCT01808586
    2016-12
  • NCT02744495
    2016-12

At the median, Betamethasone's trials enrolled 60 people — anything larger?


Median enrolment
60
Largest enrolment
3250
Registered trials counted
111

What do 1262 spontaneous reports say about Betamethasone — and not say?


These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.

Betamethasone appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 1262 reaction mentions were counted: premature baby 161; pain in extremity 149; hypersensitivity 139; urticaria 138. open-targets-adr · CHEMBL632 · 2026-06-24

Show the evidence
  • premature baby
    161
  • pain in extremity
    149
  • hypersensitivity
    139
  • urticaria
    138
  • pneumonia
    134
  • hepatic function abnormal
    120
4 more recorded rows
  • muscle spasms
    120
  • stomatitis
    113
  • epistaxis
    110
  • erythema
    78

recorded 2026-06-24 · last checked 2026-09-04

Betamethasone and CYP3A4: shared by which compounds?


CYP3A4 appear in Betamethasone's recorded interaction sentences, 2 in all. openfda-label+europepmc · 2026-04-24

Interpretation drug_interactions

Show the evidence

CYP3A4

  • drug_interactions
    Interactions with Strong CYP3A4 Inhibitors Corticosteroids (including betamethasone) are metabolized by CYP3A4.
  • drug_interactions
    Coadministration with other strong CYP3A4 inhibitors (eg, itraconazole, clarithromycin, ritonavir, cobicistat-containing products) may lead to increased exposures of corticosteroids and therefore the potential for increased risk of systemic corticosteroid side effects.

recorded 2026-04-24 · last checked 2026-09-04

Was Betamethasone studied with exercise?


exercise is named in Betamethasone's label sentences: "Compared with 432 children from the term reference cohort, ALPS children had more wheezing with exercise in the past year (7.2% betamethasone vs 4.4% term control group, adjusted RR 1.77, 95% CI, 1.03-3.06; 8.8% placebo vs term control group, adjusted RR 2.09, 95% CI, 1.25-3.48)." openfda-label+europepmc · 2026-04-24

1 recorded statement; exercise

Show the evidence
  • exercise
    Compared with 432 children from the term reference cohort, ALPS children had more wheezing with exercise in the past year (7.2% betamethasone vs 4.4% term control group, adjusted RR 1.77, 95% CI, 1.03-3.06; 8.8% placebo vs term control group, adjusted RR 2.09, 95% CI, 1.25-3.48).

recorded 2026-04-24 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL632
PubChem CID
9782
CAS number
378-44-9
RxCUI
1514
InChIKey
UREBDLICKHMUKA-DVTGEIKXSA-N

Relations

Also called
Betametasona, Flubenisolone, Lotrisone, Taclonex, betamethasone dipropionate, celestone chronodose, compound betamethasone, corticosteroid, corticosteroids, diprospan, non-particulate celestone, BETAMETHASONE ACETATE IMPURITY A [EP IMPURITY]
Trade name
Betasolan, Betnelan, Celestone, Rinderon, Diprolene, Diprosone, Valisone, Uticort, Betatrex, Betaloan SUIK, CELESTONE SOLUSPAN, Diprolene / Diprosone / Celestone / Valisone / Uticort / Betatrex
Development code
NSC-39470, SCH 4831, VISUBETA
Salt form
betamethason sodium phosphate, betamethasone sodium phosphate, compound betamethasone injection, Betamethasone Valerate, Betamethasone Acetate, Betamethasone Benzoate, Betamethasone Sodium Phosphate and Betamethasone Acetate, BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
Sources (9)

Sources

3 more sources

ChEMBL ATC CC BY-SA · ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · Open Targets 26.06 — CC0 · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 5 required field(s) not terminal: Why people use it, Best-supported result, Most important common problem, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 9 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.